PTC Therapeutics (PTCT)
63.09
+0.17 (0.27%)
Upcoming Events
Latest Headlines
PTC Therapeutics (PTCT) PT Lowered to $106 at Raymond James
October 20, 2026 6:35 AM - StreetInsider
Form 4 PTC THERAPEUTICS, INC. For: Oct 14 Filed by: SCHMERTZLER MICHAEL
October 16, 2026 5:20 PM - SEC Filing
Truist Securities Starts PTC Therapeutics (PTCT) at Hold
October 16, 2026 5:18 AM - StreetInsider
PTC Therapeutics (PTCT) PT Raised to $90 at UBS
October 15, 2026 9:17 AM - StreetInsider
PTC Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, Oct. 29, 2026
October 15, 2026 8:00 AM - PR NewsWire
Form 4 PTC THERAPEUTICS, INC. For: Oct 09 Filed by: Boulding Mark Elliott
October 13, 2026 5:20 PM - SEC Filing
Form 4 PTC THERAPEUTICS, INC. For: Oct 07 Filed by: SCHMERTZLER MICHAEL
October 9, 2026 5:20 PM - SEC Filing
Form 144 PTC THERAPEUTICS, INC. Filed by: Boulding Mark Elliott
October 9, 2026 4:15 PM - SEC Filing
Form 4 PTC THERAPEUTICS, INC. For: Oct 05 Filed by: Boulding Mark Elliott
October 7, 2026 5:20 PM - SEC Filing
Form 144 PTC THERAPEUTICS, INC. Filed by: SCHMERTZLER MICHAEL
October 7, 2026 4:38 PM - SEC Filing
RBC Capital Reiterates Sector Perform Rating on PTC Therapeutics (PTCT)
October 7, 2026 5:02 AM - StreetInsider
Form 144 PTC THERAPEUTICS, INC. Filed by: Boulding Mark Elliott
October 6, 2026 4:07 PM - SEC Filing
Form 144 PTC THERAPEUTICS, INC. Filed by: Boulding Mark Elliott
October 5, 2026 4:21 PM - SEC Filing
Form 4 PTC THERAPEUTICS, INC. For: Sep 30 Filed by: STEELE GLENN JR MD PHD
October 2, 2026 5:20 PM - SEC Filing
Form 144 PTC THERAPEUTICS, INC. Filed by: STEELE GLENN JR MD PHD
September 30, 2026 1:27 PM - SEC Filing
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 25, 2026 4:30 PM - PR NewsWire
PTC Therapeutics (PTCT) PT Raised to $137 at Cantor Fitzgerald on ST-920 Acquisition
September 22, 2026 7:49 AM - StreetInsider
Form 8-K PTC THERAPEUTICS, INC. For: Sep 21
September 21, 2026 4:36 PM - SEC Filing
PTC Therapeutics acquires Fabry disease gene therapy from Sangamo
September 21, 2026 4:30 PM - StreetInsider
PTC Completes Acquisition of ST-920 Fabry Disease Gene Therapy
September 21, 2026 4:30 PM - PR NewsWire
Form 4 PTC THERAPEUTICS, INC. For: Sep 16 Filed by: SCHMERTZLER MICHAEL
September 18, 2026 5:20 PM - SEC Filing
Leerink Assumes PTC Therapeutics (PTCT) at Outperform
September 14, 2026 6:12 AM - StreetInsider
Form 4 PTC THERAPEUTICS, INC. For: Sep 09 Filed by: SCHMERTZLER MICHAEL
September 11, 2026 5:20 PM - SEC Filing
Form 4 PTC THERAPEUTICS, INC. For: Aug 26 Filed by: SCHMERTZLER MICHAEL
August 28, 2026 5:20 PM - SEC Filing
Form 8-K PTC THERAPEUTICS, INC. For: Aug 25
August 28, 2026 4:07 PM - SEC Filing
PTC Therapeutics to Participate in Upcoming Investor Conferences
August 27, 2026 8:00 AM - PR NewsWire
Form 144/A PTC THERAPEUTICS, INC. Filed by: SCHMERTZLER MICHAEL
August 25, 2026 4:23 PM - SEC Filing
PTC Therapeutics to present Sephience PKU data at SSIEM 2026
August 24, 2026 8:01 AM - StreetInsider
PTC Therapeutics Announces New Sephience™ (sepiapterin) Data Reinforcing Broad Patient Benefits Including Sustained Metabolic Control and Diet Liberalization as well as Consistent Favorable Safety P
August 24, 2026 8:00 AM - PR NewsWire
Form 4 PTC THERAPEUTICS, INC. For: Aug 19 Filed by: SCHMERTZLER MICHAEL
August 21, 2026 5:20 PM - SEC Filing
Form 4 PTC THERAPEUTICS, INC. For: Aug 17 Filed by: Boulding Mark Elliott
August 19, 2026 5:20 PM - SEC Filing
Form 144 PTC THERAPEUTICS, INC. Filed by: SCHMERTZLER MICHAEL
August 19, 2026 4:52 PM - SEC Filing
Form 144 PTC THERAPEUTICS, INC. Filed by: Boulding Mark Elliott
August 17, 2026 11:20 AM - SEC Filing
PTC Therapeutics (PTCT) PT Raised to $122 at Barclays
August 14, 2026 4:21 AM - StreetInsider
PTC Therapeutics (PTCT) PT Raised to $109 at Wells Fargo
August 13, 2026 8:42 AM - StreetInsider
Form 8-K PTC THERAPEUTICS, INC. For: Aug 12
August 13, 2026 7:00 AM - SEC Filing
PTC wins bid for Sangamo's Fabry disease gene therapy in bankruptcy
August 12, 2026 4:02 PM - StreetInsider
PTC to Expand Rare Disease Portfolio with Acquisition of BLA-Stage ST-920 Fabry Disease Program
August 12, 2026 4:01 PM - PR NewsWire
Form 4 PTC THERAPEUTICS, INC. For: Aug 04 Filed by: Klein Matthew B.
August 6, 2026 5:20 PM - SEC Filing
Form 144 PTC THERAPEUTICS, INC. Filed by: Klein Matthew B.
August 4, 2026 3:12 PM - SEC Filing
PTC Therapeutics (PTCT) PT Raised to $106 at Wells Fargo
July 31, 2026 8:39 AM - StreetInsider
PTC Therapeutics (PTCT) PT Raised to $104 at Morgan Stanley
July 31, 2026 8:01 AM - StreetInsider
Form 4 PTC THERAPEUTICS, INC. For: Jul 28 Filed by: Sollie-Zetlmayer Hege Elisabeth
July 30, 2026 9:02 PM - SEC Filing
Form 3 PTC THERAPEUTICS, INC. For: Jul 28 Filed by: Sollie-Zetlmayer Hege Elisabeth
July 30, 2026 9:00 PM - SEC Filing
Form 10-Q PTC THERAPEUTICS, INC. For: Jun 30
July 30, 2026 4:33 PM - SEC Filing
Form 8-K PTC THERAPEUTICS, INC. For: Jul 28
July 30, 2026 4:06 PM - SEC Filing
PTC Therapeutics (PTCT) Tops Q2 EPS by 60c ; Offers Guidance
July 30, 2026 4:03 PM - StreetInsider
PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
July 30, 2026 4:01 PM - PR NewsWire
PTC Therapeutics (PTCT) PT Lowered to $93 at Morgan Stanley
July 23, 2026 8:44 AM - StreetInsider
Hamilton Lane adds Michael Schmertzler to its board of directors
July 23, 2026 7:00 AM - StreetInsider
Hamilton Lane Board Elects Michael Schmertzler as New Independent Director
July 23, 2026 7:00 AM - PR NewsWire
Full Article List
